Grants and Contributions:

Back to search

Title:

Fall detection and prevention

Agreement Number:

911107

Agreement Value:

$198,656.99

Agreement Date:

Aug 1, 2018 - Mar 31, 2020

Description:

Project is to develop a system that identifies biomarkers to predict Alzheimer Disease, a few years before the actual symptoms of the Neurodegenerative Disease (NDD) are fully apparent. Machine Learning algorithms will be used on collected sensor data, recorded by ROVER, a wearable gait analysis device developed by Sensoplex. The algorithms compare walking motion data of patients who have been diagnosed with Mild Cognitive Impairment (MCI) or Alzheimer Disease (AD) against healthy individuals of same age and gender to find digital biomarkers that separate healthy subjects form the patients with MCI or AD.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Calgary, Alberta, CA T3E 6L1

Reference Number:

172-2018-2019-Q2-911107

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

763109295

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days. The total amended value is -21,243.65 dollars.

Amendment Date

Feb 12, 2020

Recipient's Legal Name:

Sensoplex Canada Inc.

Federal Riding Name:

Calgary Centre

Federal Riding Number:

48004

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

417310

Amendments:

See Amendments